Eclat Srl.: Clinical Trials

3 trials sponsored by Eclat Srl., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1

Follow Eclat Srl.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia
JUUL E-CIGARETTE - Smoking, Schizophrenia Spectrum and Other Psychotic Disorders
Not applicableUnknownUniversity of Catania2602021-10-302024-05-08
Changes in Oral Health in Tobacco Cigarettes Smokers After Switching to Combustion-Free Nicotine Delivery Systems
TOBACCO CIGARETTES, COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS), NOT SMOKING - Gingivitis, Periodontal Diseases
Not applicableCompletedEclat Srl.4602021-10-182025-09-08
Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems
TOBACCO CIGARETTES, COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS) - Cardiovascular Risk Factor, Diabetes Mellitus, Type 2
Not applicableUnknownEclat Srl.5762021-09-272022-10-27

Conditions studied

Vaping (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Gingivitis (1)  ·  Metabolic Syndrome (1)  ·  Periodontal Diseases (1)  ·  Periodontitis (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Smoking (1)  ·  Tooth Discoloration (1)

Interventions

Tobacco Products (2)

Countries

Italy (2)  ·  United Kingdom (1)

Top investigators

Antonio Pacino, D.D.S. (1)  ·  Pankaj Sharma, PhD (1)  ·  Pasquale Caponnetto (1)

Results publications

PMID 33906842, PMID 35266059, PMID 37443061, PMID 38393754